Literature DB >> 2118934

Interclonal and intraclonal diversity among anti-DNA antibodies from an (NZB x NZW)F1 mouse.

T N Marion1, D M Tillman, N T Jou.   

Abstract

The immunologic basis for the generation of autoantibodies that are characteristic of systemic autoimmunity in mice and humans remains obscure. Experiments directed toward the analysis of serum antibody and the cell populations that combine to generate antibody in autoimmune mice have led to the proposition that autoantibody production, including anti-DNA, results from the nonselective, polyclonal activation of B cells. The present results from the molecular analyses of anti-DNA autoantibodies from an individual (NZB x NZW)F1 autoimmune mouse, however, are inconsistent with a clonally nonselective model for autoantibody production and are most consistent with a clonally selective, Ag-driven model for anti-DNA autoantibody production. These results demonstrate that Ig V region structures contributed by germ-line V region genes; recombinational diversity, including unusual DH gene usage and DH-DH recombination; and somatic mutation during B cell clonal expansion are all important for generating antibody and presumably B cell Ig receptor specificity for nucleic acids including native, duplex DNA.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2118934

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  19 in total

1.  The evolution of human anti-double-stranded DNA autoantibodies.

Authors:  Ute Wellmann; Miriam Letz; Martin Herrmann; Sieglinde Angermüller; Joachim R Kalden; Thomas H Winkler
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-20       Impact factor: 11.205

2.  Predominant role for activation-induced cytidine deaminase in generating IgG anti-nucleosomal antibodies of murine SLE.

Authors:  Thiago Detanico; Wenzhong Guo; Lawrence J Wysocki
Journal:  J Autoimmun       Date:  2015-01-26       Impact factor: 7.094

3.  Experimental expression in mice and spontaneous expression in human SLE of polyomavirus T-antigen. A molecular basis for induction of antibodies to DNA and eukaryotic transcription factors.

Authors:  O P Rekvig; U Moens; A Sundsfjord; G Bredholt; A Osei; H Haaheim; T Traavik; E Arnesen; H J Haga
Journal:  J Clin Invest       Date:  1997-04-15       Impact factor: 14.808

4.  Molecular and structural analysis of nuclear localizing anti-DNA lupus antibodies.

Authors:  M H Foster; T Kieber-Emmons; M Ohliger; M P Madaio
Journal:  Immunol Res       Date:  1994       Impact factor: 2.829

Review 5.  Autoreactive T cells in murine lupus: origins and roles in autoantibody production.

Authors:  J Craft; S Peng; T Fujii; M Okada; S Fatenejad
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

6.  Primary sequence and location of the idiotopes of V-88, a DNA-binding monoclonal autoantibody, determined by idiotope scanning with synthetic peptides on pins.

Authors:  N A Staines; F J Ward; A N Denbury; J Mitchiner; O Hartley; D Eilat; D A Isenberg; S Bansal
Journal:  Immunology       Date:  1993-03       Impact factor: 7.397

Review 7.  Abnormalities in the regulation of variable region genes that encode for antibodies to DNA may be a central factor in the pathogenesis of systemic lupus erythematosus.

Authors:  A K Singh
Journal:  Ann Rheum Dis       Date:  1993-05       Impact factor: 19.103

8.  Independently derived murine glomerular immune deposit-forming anti-DNA antibodies are encoded by near-identical VH gene sequences.

Authors:  M S Katz; M H Foster; M P Madaio
Journal:  J Clin Invest       Date:  1993-02       Impact factor: 14.808

9.  Molecular characterization of J558 genes encoding tight-skin mouse autoantibodies: identical heavy-chain variable genes code for antibodies with different specificities.

Authors:  K N Kasturi; X Y Yio; C A Bona
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-16       Impact factor: 11.205

10.  The central role of chromatin in autoimmune responses to histones and DNA in systemic lupus erythematosus.

Authors:  R W Burlingame; M L Boey; G Starkebaum; R L Rubin
Journal:  J Clin Invest       Date:  1994-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.